Cargando…
Decreased mortality among hospitalized coronavirus disease 2019 patients who underwent anticoagulant therapy with heparin
Autores principales: | Yethindra, Vityala, Tagaev, Tugolbai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722915/ https://www.ncbi.nlm.nih.gov/pubmed/33078738 http://dx.doi.org/10.4103/ijp.IJP_584_20 |
Ejemplares similares
-
Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19
por: Vityala, Yethindra, et al.
Publicado: (2021) -
Evaluation of Cardiovascular Diseases and Diabetes Mellitus as Predisposing Factors for Mortality in Patients with Coronavirus Disease 2019: Systematic Review and Meta-Analysis
por: Yethindra, Vityala, et al.
Publicado: (2021) -
A rare case of patient with neurofibromatosis type 1 in a genotype–phenotype correlation revealing a submicroscopic deletion on the long arm of chromosome 17
por: Yethindra, Vityala, et al.
Publicado: (2021) -
Fine‐needle aspiration cytology‐based accurate and rapid diagnosis of breast tuberculosis mimicking an abscess
por: Vityala, Yethindra, et al.
Publicado: (2021) -
A rare case of concurrent pulmonary and hepatic hydatid cysts treated by single‐stage surgical management
por: Toktogaziev, Bakyt, et al.
Publicado: (2022)